|
gptkbp:instance_of
|
gptkb:tobacco
|
|
gptkbp:associated_with
|
increased quit rates
reduced withdrawal symptoms
|
|
gptkbp:available_in
|
various flavors
|
|
gptkbp:available_in_strengths
|
2 mg
4 mg
|
|
gptkbp:available_over_the_counter
|
gptkb:true
|
|
gptkbp:brand
|
gptkb:Nicorette
|
|
gptkbp:can_be_used_with
|
other cessation aids
|
|
gptkbp:can_cause
|
gptkb:addiction
dependence
|
|
gptkbp:care_instructions
|
allow to dissolve in mouth
do not chew or swallow
|
|
gptkbp:clinical_trial
|
demonstrated effectiveness
|
|
gptkbp:contains
|
nicotine
|
|
gptkbp:contraindication
|
pregnancy
heart disease
|
|
gptkbp:dosage_form
|
gptkb:Loewe
1 lozenge every 1-2 hours
|
|
gptkbp:duration
|
up to 12 weeks
|
|
gptkbp:first_introduced
|
1990s
|
|
gptkbp:flavor
|
gptkb:cinnamon
gptkb:fruit
gptkb:mint
vanilla
cherry
|
|
gptkbp:formulation
|
oral
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Nicorette Mini Lozenge
|
|
gptkbp:ingredients
|
nicotine
|
|
gptkbp:is_considered
|
a safe alternative to smoking
|
|
gptkbp:is_part_of
|
Nicotine replacement therapy products
|
|
gptkbp:is_recommended_by
|
gptkb:healthcare_professionals
|
|
gptkbp:is_used_in
|
gptkb:psychotherapy
|
|
gptkbp:manufacturer
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:marketed_as
|
aids to quit smoking
|
|
gptkbp:packaging
|
blister pack
|
|
gptkbp:regulatory_compliance
|
FDA approved
|
|
gptkbp:side_effect
|
dizziness
headache
nausea
coughing
throat irritation
|
|
gptkbp:storage
|
store at room temperature
|
|
gptkbp:suitable_for
|
pregnant women
non-smokers
breastfeeding women
under 18 years old
|
|
gptkbp:target_audience
|
smokers
|
|
gptkbp:used_for
|
smoking cessation
|
|
gptkbp:user_reviews
|
generally positive
|
|
gptkbp:bfsParent
|
gptkb:GSK_Consumer_Healthcare
|
|
gptkbp:bfsLayer
|
6
|